共 50 条
- [31] Safety of anakinra (Interleukin-1 receptor antagonist) in rheumatoid arthritis (RA) subjects with potential high risk for infection [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S343 - S343
- [35] The Prospect of Treating Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist [J]. BioDrugs, 2001, 15 : 87 - 97
- [36] EFFECTS OF ETODOLAC ON METHOTREXATE (MTX) PHARMACOKINETICS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S343 - S343
- [37] Effects of interleukin-1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 899 - 899
- [38] Interleukin-1 β and interleukin receptor antagonist gene polymorphisms:: Relationship to occurrence and severity of rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S64 - S64
- [40] Assessment of the synovial fluid interleukin-1 receptor antagonist (IL-1Ra)/interleukin-1 beta (IL-1beta) ratio in patients with osteoarthritis and rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S575 - S575